Literature DB >> 15682054

Safety of contrast dobutamine stress echocardiography: a single center experience.

Jonathan Timperley1, Andrew R J Mitchell, Helene Thibault, Intisar H Mirza, Harald Becher.   

Abstract

BACKGROUND: Contrast is increasingly being used during dobutamine stress echocardiography. However, there are few data regarding the safety of this combination.
METHODS: We retrospectively analyzed 751 consecutive stress echocardiograms, 332 without contrast and 419 with contrast (299 with Sonouve, 120 with Optison). Reported side effects and physiologic data were then compared.
RESULTS: There were no fatalities. The incidence of side effects was similar in the 3 groups. The Optison group had a lower diastolic blood pressure compared with the noncontrast group ( P < .05) at rest, and the Sonovue group had a higher peak heart rate compared with the noncontrast group ( P < .001). Patients receiving Optison had more premature atrial contractions ( P < .05) but there was no difference in the incidence of ventricular tachycardia, supraventricular tachycardia, or vagally mediated episodes.
CONCLUSION: The use of contrast during dobutamine stress echocardiography was not associated with an increased risk of side effects.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15682054     DOI: 10.1016/j.echo.2004.09.003

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  7 in total

1.  Clinical application and laboratory protocols for performing contrast echocardiography.

Authors:  Adrian Chong; Brian Haluska; Sudhir Wahi
Journal:  Indian Heart J       Date:  2013-04-06

2.  The value of contrast dobutamine stress echocardiography on detecting coronary artery disease in overweight and obese patients.

Authors:  Shen-Jiang Hu; Sheng-Xiang Liu; H A Katus; M Luedde
Journal:  Can J Cardiol       Date:  2007-09       Impact factor: 5.223

3.  Stress echocardiography with contrast for the diagnosis of coronary artery disease: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2010-06-01

4.  ST-segment elevation associated with allergic reaction to echocardiographic contrast agent administration.

Authors:  Ag van Ginkel; Bj Sorgdrager; M A de Graaf; I Karalis; N Ajmone Marsan
Journal:  Neth Heart J       Date:  2014-02       Impact factor: 2.380

5.  Contrast-enhanced ultrasound for evaluation of high-intensity focused ultrasound treatment of benign uterine diseases: retrospective analysis of contrast safety.

Authors:  Chong-Qing Cheng; Rui-Tao Zhang; Yu Xiong; Li Chen; Jian Wang; Guo-Hua Huang; Ke-Quan Li; Lian Zhang; Jin Bai
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

6.  The potential clinical value of contrast-enhanced echocardiography beyond current recommendations.

Authors:  Malin K Larsson; Cristina Da Silva; Elif Gunyeli; Ali Akebat Bin Ilami; Karolina Szummer; Reidar Winter; Anna Bjällmark
Journal:  Cardiovasc Ultrasound       Date:  2016-01-05       Impact factor: 2.062

7.  Utility and safety of three-dimensional contrast low-dose dobutamine echocardiography in the evaluation of myocardial viability early after an acute myocardial infarction.

Authors:  Piotr Scisło; Janusz Kochanowski; Łukasz Kołtowski; Grzegorz Opolski
Journal:  Arch Med Sci       Date:  2016-03-17       Impact factor: 3.318

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.